Glucagon Peptide Market 2024: Composition, Brand Comparison, and Industry Trends Analysis
Published: July 13, 2026 14:07
Author: Matthew Mercier
Abstract: Glucagon, a 29-amino acid peptide hormone, is critical for glucose homeostasis. The 2024 market is driven by innovations in synthetic and recombinant analogs, with key brands like GlucaGen and Baqsimi offering distinct delivery systems (injectable vs. nasal). Current trends emphasize stability, cold-chain logistics, and regulatory compliance (FDA/EMA). Comparative analysis reveals trade-offs between rapid onset and shelf-life. Industry growth is fueled by expanding applications beyond hypoglycemia, including metabolic disorders, demanding rigorous factory资质 and certificate validation for quality assurance.